AI test could predict effective cancer drug combinations in less than two days
April 4, 2022Sales and Marketing
Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in …
FDA accepts Dupixent for Priority Review in patients 12+ with eosinophilic esophagitis
April 4, 2022Sales and Marketing
The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 …
New centre targets ‘undruggable’ cancers
April 4, 2022Sales and Marketing
The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of …
COVID-19 vaccines now available for five to 11-year olds in England
April 4, 2022Sales and Marketing
Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. …
FDA places two clinical holds on CytoDyn HIV and COVID-19 programmes
April 1, 2022Medical Communications
The FDA has placed a partial hold on CytoDyn’s HIV program, and a full clinical hold on its COVID-19 program …
Biomodex launches clear cartridges for neurovascular training
April 1, 2022Medical Communications
Biomodex has announced the launch of clear cartridges for use with Biomodex’s EVIAS and EVIAS Plus stations.The cartridges are 3D …
Isturisa effective in treating rare Cushing’s disease
April 1, 2022Medical Communications
Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy …
UK app launched for people living with glaucoma
April 1, 2022Medical Communications
Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …
New research finds patient satisfaction with GP services has dropped since pre-pandemic
March 31, 2022GP leaders have said that it is ‘unsurprising’ that more people are dissatisfied with the NHS than are satisfied, and …
FDA approval of Cabenuva for adolescents living with HIV
March 31, 2022Business Services
ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …
Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma
March 31, 2022Business Services
An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …
250,000 with diabetes to benefit from real time information after updated NICE recommendations
March 31, 2022Business Services
Over 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their …
Kesimpta-treated adults with multiple sclerosis not at risk of severe COVID-19
March 30, 2022Business Services
The peer-reviewed journal Neurology and Therapy has published new data on COVID-19 infections in people living with remitting multiple sclerosis …
Carthera’s SonoCloud demonstrates potential in Alzheimer’s patients
March 30, 2022Business Services
Carthera has announced the publication of results in the Alzheimer’s Research & Therapy Journal, from an investigator-sponsored trial evaluating the …
Iktos announces a collaboration with Ono for new drug design
March 30, 2022Research and Development
Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …
$24 million in grants to help end HIV epidemic across the globe
March 30, 2022Research and Development
Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …
Margaret Keegan joins RQM+ as new CEO
March 29, 2022RQM+, a world leading provider of regulatory, clinical and quality solutions to the MedTech industry, announced the appointment of life …
Injecting real-world data into every day clinical trials – RWE and RWD
March 29, 2022The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …
Preparation Preconditions: What measures are needed to combat another pandemic?
March 29, 2022Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …
CHMP recommends approval of Janssen’s first CAR-T therapy
March 29, 2022Manufacturing and Production
Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
